Trial reportUpdates in surgery2021
Cholecystectomy using the Revo-i robotic surgical system from Korea: the first clinical study.
Trial report in Updates in surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- New Robotic Platforms in General Surgery: What's the Current Clinical Scenario?Medicina (Kaunas, Lithuania) · 2023Pooled it
- Cholecystectomy with the Hugo™ robotic-assisted surgery system: the first general surgery clinical study in Korea.Surgical endoscopy · 2025Trial
- The Revo-i Robotic Surgical System in Advanced Pancreatic Surgery: A Second Non-Randomized Clinical Trial and Comparative Analysis to the da Vinci™ System.Yonsei medical journal · 2024Trial
- Robotic left lateral sectionectomy using the Hugo™ Robotic-Assisted Surgery system: a case report.International journal of surgery case reports · 2026Article
- Reduced port robotic cholecystectomy using the Revo-i single-site plus ONE port approach: a case series with video.Journal of minimally invasive surgery · 2026Article
- A right colectomy case study: transitioning to the Hugo RAS system with a novel 3-ports technique in experienced robotic colorectal practice.Langenbeck's archives of surgery · 2024Article
- ArtiSential laparoscopic cholecystectomy: a comparative analysis with robotic single-port cholecystectomy.Annals of surgical treatment and research · 2024Article
- Evaluation status of current and emerging minimally invasive robotic surgical platforms.Surgical endoscopy · 2024Review
- Single-site robotic cholecystectomy versus single-incision laparoscopic cholecystectomy: A systematic review and meta-analysis.Annals of gastroenterological surgery · 2023Review
- Safety and Feasibility of Cholecystectomy with the HugoVisceral medicine · 2023Article
- User interfaces for actuated scope maneuvering in surgical systems: a scoping review.Surgical endoscopy · 2023Article
- Which one will you choose; open, laparoscopic, or robotic transduodenal ampullectomy?: a case report.Journal of minimally invasive surgery · 2022Article
- Study on the Application Effect of Fast Track Surgery Care Combined With Continuous Care After Discharge in Patients With Laparoscopic Cholecystectomy.Frontiers in surgery · 2022Article
- Robotic Surgery: At the Crossroads of a Data Explosion.World journal of surgery · 2021Review
- Comparison of outcomes of single incision robotic cholecystectomy and single incision laparoscopic cholecystectomy.Annals of hepato-biliary-pancreatic surgery · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
This study evaluated the safety and efficacy of the newly developed Revo-i (Meerecompany, Yongin, Republic of Korea) robotic surgical system during robot-assisted cholecystectomy. This prospective, phase I clinical study involved 15 patients with gallbladder-related disease. The primary outcome evaluated was the intraoperative safety of the Revo-i; the secondary outcomes measured were the 30-day postoperative complications and patient satisfaction with the Revo-i's performance. Between August 17 and December 23, 2016, we performed 15 robot-assisted cholecystectomies. The operations were successfully completed, without any conversions to open or laparoscopic approaches. The mean patient age (53.07 years), mean operative time (115.3 ± 17.31 min [± standard deviation]), docking time (10.6 ± 3.16 min), console time (49.7 ± 15.41 min), actual dissection time (33.1 ± 10.53 min), and estimated blood loss (3.33 ± 6.17 mL) were determined. There were no intra- or postoperative complications, including gallbladder perforations. The mean hospital stay was 2.0 ± 1.00 days. Most patients reported satisfaction with the Revo-i's performance. Performing robot-assisted cholecystectomies using the Revo-i is feasible and safe. This report describes the first clinical study of the Revo-i robotic surgical system in human patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.